Cargando…
Costs of patients with chronic kidney disease in Germany
BACKGROUND: This study aimed to determine the costs and distribution of healthcare spending of patients with chronic kidney disease (CKD) at stages 3 and 4 and on dialysis both at the individual and population level in Germany. METHODS: The study took the perspective of the German statutory health i...
Autores principales: | Gandjour, Afschin, Armsen, Wencke, Wehmeyer, Wolfgang, Multmeier, Jan, Tschulena, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182232/ https://www.ncbi.nlm.nih.gov/pubmed/32330140 http://dx.doi.org/10.1371/journal.pone.0231375 |
Ejemplares similares
-
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
por: Gandjour, Afschin
Publicado: (2023) -
Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results
por: Gandjour, Afschin
Publicado: (2020) -
How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany
por: Gandjour, Afschin
Publicado: (2021) -
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment
por: Gandjour, Afschin
Publicado: (2023) -
The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany
por: Gandjour, Afschin
Publicado: (2022)